You are here — Home > Publications > HTB > October 2006 > 46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco

RSS Atom • ISSN 1472-4683 • Subscribe • About

Conference reports

Published: October 2006. Related: Conference index, ICAAC 46th San Francisco 2006.

46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco

This US-based annual conference has generally reversed its trend for reduced HIV coverage, by including several important studies of new drugs.

Reports from this meeting

MK-0518 demonstrates potent efficacy in patients with triple-class resistant virus: 24 week results

Lipid profile of integrase inhibitor MK-0518: 24 week results compared to efavirenz in treatment naive patients

Cell studies predict cross-resistance among integrase inhibitors

HIV may use different coreceptors in blood and brain

Critical interactions between darunavir (TMC114), lopinavir, Viagra, and oral contraceptives

NRTI elvucitabine active against HIV in a 7-day monotherapy study

Efavirenz/tenofovir fails as 2-drug maintenance regimen

Nucleoside inhibitor MK-0608 mediates suppression of HCV replication for >30 days in chronically infected chimpanzees

Links to external websites are current at time of posting but not maintained.

HTB

Latest

Special report

Conference reports

46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco